$7.53
-0.27-3.46%
À la fermeture: -
$7.46
-0.07-0.93%
Après les heures de négociation: Oct 17, 4:01 PM EDT
Comments
Loading...
Orientation et prévision
Evolent Health publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
09/23/2025 | EVH | Evolent Health | FY | 2025 | — | — | — | $1.85B | $1.88B | $1.88B | |
09/23/2025 | EVH | Evolent Health | Q3 | 2025 | — | — | — | $460.00M | $480.00M | $470.82M | |
08/07/2025 | EVH | Evolent Health | Q3 | 2025 | — | — | — | $460.00M | $480.00M | $506.12M | |
08/07/2025 | EVH | Evolent Health | FY | 2025 | — | — | — | $1.85B | $1.88B | $2.06B | |
06/03/2025 | EVH | Evolent Health | Q2 | 2025 | — | — | — | $440.00M | $470.00M | $459.43M | |
06/03/2025 | EVH | Evolent Health | FY | 2025 | — | — | — | $2.06B | $2.11B | $2.05B | |
05/08/2025 | EVH | Evolent Health | FY | 2025 | — | — | — | $2.06B | $2.11B | $2.07B | |
05/08/2025 | EVH | Evolent Health | Q2 | 2025 | — | — | — | $440.00M | $470.00M | $503.67M | |
02/20/2025 | EVH | Evolent Health | FY | 2025 | — | — | — | $2.06B | $2.11B | $2.42B | |
02/20/2025 | EVH | Evolent Health | Q1 | 2025 | — | — | — | $440.00M | $470.00M | $592.10M | |
11/07/2024 | EVH | Evolent Health | FY | 2024 | — | — | — | $2.55B | $2.58B | $2.58B | |
11/07/2024 | EVH | Evolent Health | Q4 | 2024 | — | — | — | $642.00M | $667.00M | $663.03M | |
08/08/2024 | EVH | Evolent Health | Q3 | 2024 | — | — | — | $615.00M | $635.00M | $644.40M | |
08/08/2024 | EVH | Evolent Health | FY | 2024 | — | — | — | $2.56B | $2.60B | $2.58B | |
05/09/2024 | EVH | Evolent Health | FY | 2024 | — | — | — | $2.53B | $2.60B | $2.47B | |
05/09/2024 | EVH | Evolent Health | Q2 | 2024 | — | — | — | $625.00M | $645.00M | $606.64M | |
02/22/2024 | EVH | Evolent Health | FY | 2024 | — | — | — | $2.40B | $2.50B | $2.32B | |
02/22/2024 | EVH | Evolent Health | Q1 | 2024 | — | — | — | $595.00M | $610.00M | $552.49M | |
11/02/2023 | EVH | Evolent Health | Q4 | 2023 | — | — | — | $537.00M | $557.00M | $545.42M | |
11/02/2023 | EVH | Evolent Health | FY | 2023 | — | — | — | $1.95B | $1.97B | $1.95B | |
08/02/2023 | EVH | Evolent Health | FY | 2023 | — | — | — | $1.94B | $1.97B | $1.95B | |
08/02/2023 | EVH | Evolent Health | Q3 | 2023 | — | — | — | $500.00M | $520.00M | $522.29M | |
05/23/2023 | EVH | Evolent Health | FY | 2023 | — | — | — | $1.95B | $1.95B | $1.95B | |
05/03/2023 | EVH | Evolent Health | FY | 2023 | — | — | — | $1.94B | $1.97B | $1.94B | |
05/03/2023 | EVH | Evolent Health | Q2 | 2023 | — | — | — | $455.00M | $470.00M | $464.93M | |
02/22/2023 | EVH | Evolent Health | FY | 2023 | — | — | — | $1.92B | $1.96B | $1.76B | |
02/22/2023 | EVH | Evolent Health | Q1 | 2023 | — | — | — | $420.00M | $440.00M | $410.36M | |
01/11/2023 | EVH | Evolent Health | FY | 2022 | — | — | — | $1.33B | $1.35B | $1.34B | |
11/02/2022 | EVH | Evolent Health | FY | 2022 | — | — | — | $1.33B | $1.35B | $1.35B | |
11/02/2022 | EVH | Evolent Health | Q4 | 2022 | — | — | — | $361.00M | $381.00M | $376.16M | |
08/02/2022 | EVH | Evolent Health | FY | 2022 | — | — | — | $1.32B | $1.36B | $1.22B | |
08/02/2022 | EVH | Evolent Health | Q3 | 2022 | — | — | — | $343.00M | $363.00M | $312.69M | |
06/29/2022 | EVH | Evolent Health | Q2 | 2022 | — | — | — | $290.00M | $305.00M | $297.77M | |
06/29/2022 | EVH | Evolent Health | FY | 2022 | — | — | — | $1.16B | $1.21B | $1.21B | |
05/04/2022 | EVH | Evolent Health | FY | 2022 | — | — | — | $1.16B | $1.21B | $1.16B | |
05/04/2022 | EVH | Evolent Health | Q2 | 2022 | — | — | — | $290.00M | $305.00M | $285.39M | |
02/23/2022 | EVH | Evolent Health | Q1 | 2022 | — | — | — | $280.00M | $295.00M | $250.06M | |
02/23/2022 | EVH | Evolent Health | FY | 2022 | — | — | — | $1.12B | $1.18B | $1.04B | |
01/11/2022 | EVH | Evolent Health | FY | 2021 | — | — | — | $884.00M | $900.00M | $896.15M | |
11/03/2021 | EVH | Evolent Health | Q4 | 2021 | — | — | — | $225.00M | $240.00M | $227.18M | |
11/03/2021 | EVH | Evolent Health | FY | 2021 | — | — | — | $884.00M | $900.00M | $889.77M | |
08/04/2021 | EVH | Evolent Health | FY | 2021 | — | — | — | $870.00M | $900.00M | $870.75M | |
08/04/2021 | EVH | Evolent Health | Q3 | 2021 | — | — | — | $215.00M | $230.00M | $217.74M | |
05/05/2021 | EVH | Evolent Health | Q2 | 2021 | — | — | — | $210.00M | $225.00M | $211.85M | |
05/05/2021 | EVH | Evolent Health | FY | 2021 | — | — | — | $845.00M | $880.00M | $864.88M | |
02/25/2021 | EVH | Evolent Health | Q1 | 2021 | — | — | — | $205.00M | $215.00M | $229.29M | |
02/25/2021 | EVH | Evolent Health | FY | 2021 | — | — | — | $830.00M | $880.00M | $940.38M |
FAQ
Quelles sont les dernières directives pour Evolent Health (EVH) ?
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour Evolent Health ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.